BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11074873)

  • 1. Cerebral white matter lesions and depressive symptoms in elderly adults.
    de Groot JC; de Leeuw FE; Oudkerk M; Hofman A; Jolles J; Breteler MM
    Arch Gen Psychiatry; 2000 Nov; 57(11):1071-6. PubMed ID: 11074873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.
    de Leeuw FE; de Groot JC; Achten E; Oudkerk M; Ramos LM; Heijboer R; Hofman A; Jolles J; van Gijn J; Breteler MM
    J Neurol Neurosurg Psychiatry; 2001 Jan; 70(1):9-14. PubMed ID: 11118240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal volume and subcortical white matter lesions in late life depression: comparison of early and late onset depression.
    Janssen J; Hulshoff Pol HE; de Leeuw FE; Schnack HG; Lampe IK; Kok RM; Kahn RS; Heeren TJ
    J Neurol Neurosurg Psychiatry; 2007 Jun; 78(6):638-40. PubMed ID: 17210630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression.
    Nebes RD; Vora IJ; Meltzer CC; Fukui MB; Williams RL; Kamboh MI; Saxton J; Houck PR; DeKosky ST; Reynolds CF
    Am J Psychiatry; 2001 Jun; 158(6):878-84. PubMed ID: 11384894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of cerebral white matter lesions is not associated with development of depressive symptoms in elderly subjects at risk of cardiovascular disease: The PROSPER Study.
    Versluis CE; van der Mast RC; van Buchem MA; Bollen EL; Blauw GJ; Eekhof JA; van der Wee NJ; de Craen AJ;
    Int J Geriatr Psychiatry; 2006 Apr; 21(4):375-81. PubMed ID: 16534770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cerebral white matter lesions with cognitive function and mood in Japanese elderly people: a population-based study.
    Yamawaki M; Wada-Isoe K; Yamamoto M; Nakashita S; Uemura Y; Takahashi Y; Nakayama T; Nakashima K
    Brain Behav; 2015 Mar; 5(3):e00315. PubMed ID: 25798332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and cerebral white matter lesions in a prospective cohort study.
    de Leeuw FE; de Groot JC; Oudkerk M; Witteman JC; Hofman A; van Gijn J; Breteler MM
    Brain; 2002 Apr; 125(Pt 4):765-72. PubMed ID: 11912110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors related to prevalence, persistence, and incidence of depressive symptoms in mild cognitive impairment: vascular depression construct.
    Kim S; Woo SY; Kang HS; Lim SW; Choi SH; Myung W; Jeong JH; Lee Y; Hong CH; Kim JH; Na H; Carroll BJ; Kim DK
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):818-26. PubMed ID: 26679895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study.
    Teodorczuk A; Firbank MJ; Pantoni L; Poggesi A; Erkinjuntti T; Wallin A; Wahlund LO; Scheltens P; Waldemar G; Schrotter G; Ferro JM; Chabriat H; Bazner H; Visser M; Inzitari D; O'Brien JT;
    Psychol Med; 2010 Apr; 40(4):603-10. PubMed ID: 19671212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms in adolescents: associations with white matter volume and marijuana use.
    Medina KL; Nagel BJ; Park A; McQueeny T; Tapert SF
    J Child Psychol Psychiatry; 2007 Jun; 48(6):592-600. PubMed ID: 17537075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum carotenoids and cerebral white matter lesions: the Rotterdam scan study.
    den Heijer T; Launer LJ; de Groot JC; de Leeuw FE; Oudkerk M; van Gijn J; Hofman A; Breteler MM
    J Am Geriatr Soc; 2001 May; 49(5):642-6. PubMed ID: 11380759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent cerebral white matter lesions and their relationship with vascular risk factors in middle-aged predialysis patients with CKD.
    Martinez-Vea A; Salvadó E; Bardají A; Gutierrez C; Ramos A; García C; Compte T; Peralta C; Broch M; Pastor R; Angelet P; Marcas L; Saurí A; Oliver JA
    Am J Kidney Dis; 2006 Feb; 47(2):241-50. PubMed ID: 16431253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of cerebral small vessel disease and severity of depression in the general population.
    Direk N; Perez HS; Akoudad S; Verhaaren BF; Niessen WJ; Hofman A; Vernooij MW; Ikram MA; Tiemeier H
    Psychiatry Res Neuroimaging; 2016 Jul; 253():1-6. PubMed ID: 27254084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Small Vessel Disease and Association With Higher Incidence of Depressive Symptoms in a General Elderly Population: The AGES-Reykjavik Study.
    van Sloten TT; Sigurdsson S; van Buchem MA; Phillips CL; Jonsson PV; Ding J; Schram MT; Harris TB; Gudnason V; Launer LJ
    Am J Psychiatry; 2015 Jun; 172(6):570-8. PubMed ID: 25734354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periventricular cerebral white matter lesions predict rate of cognitive decline.
    De Groot JC; De Leeuw FE; Oudkerk M; Van Gijn J; Hofman A; Jolles J; Breteler MM
    Ann Neurol; 2002 Sep; 52(3):335-41. PubMed ID: 12205646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomic location and laterality of MRI signal hyperintensities in late-life depression.
    Tupler LA; Krishnan KR; McDonald WM; Dombeck CB; D'Souza S; Steffens DC
    J Psychosom Res; 2002 Aug; 53(2):665-76. PubMed ID: 12169341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study.
    Breteler MM; van Swieten JC; Bots ML; Grobbee DE; Claus JJ; van den Hout JH; van Harskamp F; Tanghe HL; de Jong PT; van Gijn J
    Neurology; 1994 Jul; 44(7):1246-52. PubMed ID: 8035924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacunar infarcts in deep white matter are associated with higher and more fluctuating depressive symptoms during three years follow-up.
    Grool AM; Gerritsen L; Zuithoff NP; Mali WP; van der Graaf Y; Geerlings MI
    Biol Psychiatry; 2013 Jan; 73(2):169-76. PubMed ID: 23079234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Location of cerebrovascular and degenerative changes, depressive symptoms and cognitive functioning in later life: the SMART-Medea study.
    Grool AM; van der Graaf Y; Mali WP; Geerlings MI;
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1093-100. PubMed ID: 21459931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subcortical hyperintensities on magnetic resonance imaging: a comparison of normal and depressed elderly subjects].
    Novaretti TM; Marcolin MA; Meira S; Gelás PL; Baudelin CG; Bottino CM
    Arq Neuropsiquiatr; 2001 Sep; 59(3-B):754-60. PubMed ID: 11593278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.